Sequenom Shares Rise Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Sequenom soared in Tuesday trade, even though there appeared to be no news that would create such a surge in both its price and trading volume.

Sequenom finished Tuesday up 58 percent at $5.30 on the Nasdaq. More than 53 million shares traded hands on the day — nearly 10 times its average daily trading volume.

There was no news or filings with the US Securities and Exchange Commission that would account for the spike, leading to the usual rumors on various stock trading message boards that news could be on the way.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.